Published on
Apr 9, 2025
FDA gives nod to Orthocell’s 510(k) for nerve repair product
The U.S. FDA has cleared regenerative medicine company Orthocell Ltd.’s 510(k) for its nerve repair product, Remplir, paving the way to begin commercial operations in the $1.6 billion U.S. nerve repair market. BioWorld MedTech Regulatory Orthopedics Wound …
Source:
BioWorld
-
Label Pending
